Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2009 Mar 19;29(9):1298–1303. doi: 10.1161/ATVBAHA.109.186502

Figure 1B.

Figure 1B

Preferential loss of apoA-II and SAA after SR-BI processing.

ApoA-I-/- mice were injected with 1.5×1011 particles of adenoviral vector AdSR-BI. After three days when SR-BI expression was maximal, the mice were injected with a bolus of 750 μg 125I-AP HDL (25μg LPS). Plasma samples containing remnants were collected from individual mice at the indicated times after bolus injection and 5 μl aliquots were analyzed by SDS-PAGE (5-20% acrylamide gradient). An aliquot of the injected 125I-AP HDL is shown for comparison. Samples were visualized by autoradiography.